Sofilaro
VC Fund
Montpellier, France
Sofilaro is an investment arm of Crédit Agricole S.A. specializing in late venture, mature, growth capital, buyouts, and middle market investments.
- Total investments:
- 30
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Sofilaro invests in
Stages Sofilaro invests in
Countries Sofilaro invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $526k–$5.8M
- Series A
- $1.6M–$42M
- Venture - Series Unknown
- $1.2M–$37M
Investment Focus
Industry
- Health Care 7 (23%)
- Software 4 (13%)
- Manufacturing 4 (13%)
- Renewable Energy 3 (10%)
- Food and Beverage 3 (10%)
Stage
- Venture - Series Unknown 10 (33%)
- Seed 8 (27%)
- Series A 5 (17%)
- Series B 2 (7%)
- Funding Round 2 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Constance Arnal
Investment Officer
|
Investment Officer | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Wheere
|
Wheere invented geolocation technology that works both indoors and outdoors, as opposed to GPS, which only works outdoors. Wheere is betting on the creation of a dedicated electronic chip (ASIC), the deployment of world capitals, and the launch of a satellite constellation. | $4.8M / Seed / Jun 23, 2026 | |
DiappyMed
|
DiappyMed specializes in developing platforms to calculate insulin dosages. | $5.8M / Seed / Mar 22, 2026 | |
Sim&Cure
|
Sim&Cure is the first company to be cleared to market a patient-based simulation model for aneurysm treatment that allows prediction of the deployment of medical devices (flow diverter, intrasaccular device, laser-cuter stent). Sim&Size® simulates each size and type of device according to the patient’s unique anatomy in order to provideessential information prior to the choice of sizing. | $11.6M / Series A / Nov 28, 2025 | |
Greenphage
|
Greenphage develops bacteriophage-based methods to address bacterial infections and contaminations in human, animal, and plant health. It uses bacteriophages to create alternatives to antibacterial treatments. The company conducts laboratory research on phage studies, molecular virology, and microbiology. It also works with research institutions tosupport its phage therapy efforts. | $2.2M / Seed / Jul 10, 2025 | |
Matchers
|
Matchers specialize in providing organization training courses and programs related to administration and management. | $1.3M / Venture - Series Unknown / Dec 19, 2024 | |
CILcare
|
CILcare specializes in providing drug solutions for hearing and ear disorders. | $42M / Series A / Dec 04, 2024 | |
SCOP3
|
SCOP3 is a platform that gives new life to professional equipment. SCOP3 was founded in 2021 and was headquartered in Montpellier, France. | $5.7M / Seed / May 16, 2024 | |
Kinvent
|
KINVENT is actively involved in the fields of physical rehabilitation and sports biomechanics producing innovative measuring and training devices for the facilitation of every day and athletic movements. Our strengths at KINVENT is that we can think and produce solutions to any challenge of sports biomechanics and physical rehabilitation.Triangular force plates for visual feedback balance training, sensors for continuous 3D kinematic analysis in the water, force sensors for kite surf, accelerometers for rowing and sailing, are some of our on demand products. If you are looking for excellence in hardware and software solutions for your work... work with us.Our KFORCE solution is a range of torque measuring instruments for human strength, balance and motion. This system consists of six instruments with high-precision measuring equipment, which concentrate all the know-how of K-INVENT. The display of the data recorded by the device sensors is transcribed by the KFORCE software, installed on any iOS or Android terminal. This accessory capable of reading and re-transcribing the information given by all dynamometers of the entire range is usable on smartphones or tablets with Android and IOS operating system | $17.4M / Series B / Jan 18, 2024 | |
Elements
|
Elements is a producer and supplier of green electricity. | $53.9M / Venture - Series Unknown / Dec 07, 2023 | |
Drone Geofencing
|
Drone Geofencing creates applications for remotely piloted aircraft as well as a system for remotely monitoring a fleet of drones from a command center. Drone Geofencing collaborates closely with many research teams from the CNRS and CIRA, as well as manufacturers of professional drones and several significant clients. | $1.5M / Seed / Dec 04, 2023 | |
| See all 30 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Sofilaro invest in?
Sofilaro invests primarily in Health Care, Software and Manufacturing startups, most often at Venture - Series Unknown and Seed stage. Most of the 30 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Sofilaro's check size?
Sofilaro typically joins rounds of $526k–$5.8M at Seed, $1.6M–$42M at Series A and $1.2M–$37M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sofilaro participates in.
How do I contact Sofilaro?
Public channels for Sofilaro include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Sofilaro?
The team at Sofilaro includes Constance Arnal (Investment Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
